The company has successfully eliminated its debt as of 2026Q1, though it continues to carry a $1.9 billion accumulated deficit in retained earnings.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 498.53M | 520.27M | 490.99M | 341.35M | 180.25M | 187.21M | 199.86M | 141.61M | 166.06M | 95.97M | 116.11M | 115.89M | 153.41M | 67.06M | 98.42M | 125.63M | 195.02M | 117.78M | 168.25M | 213.37M | 217.15M | 195.65M | 124.78M | 111.81M | 50.77M | 71.7M | 34.59M | 40.4M | 25.8M | 23.5M | 25M |
| Cash & Short-Term Investments | 314.29M | 359.8M | 406.57M | 333.7M | 172.75M | 183.72M | 196.28M | 139.32M | 163.56M | 94.95M | 115.11M | 114.04M | 151.71M | 65.22M | 96.33M | 121.31M | 186.57M | 111.61M | 162.84M | 206M | 213.33M | 190.47M | 119.96M | 109.25M | 46.99M | 68.94M | 33.02M | 7.8M | 16.4M | 4.1M | 12.4M |
| Cash Only | 70.78M | 79.44M | 79.02M | 70.02M | 56.84M | 34.87M | 9.93M | 13.64M | 10.84M | 16.6M | 13.08M | 21.52M | 43.06M | 12.99M | 22.86M | 16.11M | 45.97M | 34.6M | 109.35M | 146.03M | 135.88M | 96.63M | 9.85M | 12.82M | 4.6M | 18.77M | 29.98M | 7.8M | 16.4M | 4.1M | 12.4M |
| Short-Term Investments | 243.51M | 280.36M | 327.55M | 263.68M | 115.9M | 148.85M | 186.35M | 125.68M | 152.71M | 78.35M | 102.03M | 92.52M | 108.64M | 52.23M | 73.47M | 105.21M | 140.6M | 77.01M | 53.49M | 59.98M | 77.45M | 93.84M | 110.12M | 96.43M | 42.38M | 50.17M | 3.04M | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 39.23M | 38.8M | 1.66M | 3.14M | 1.76M | 722K | 802K | 1.17M | 436K | 475K | 1.21M | 963K | 564K | 752K | 1.4M | 1.8M | 1.32M | 882K | 788K | 1.27M | 2.3M | 1.7M | 1.21M | 1.14M | 1.52M | 1.21M | 700K | 500K | 900K | 0 |
| Days Sales Outstanding | 53.02 | 77.86 | 183.93 | 2.55K | 1.93K | 461.95 | 1.04K | 636.37 | 399.93 | 149.43 | 28.14 | 12.1 | 304.85 | 160.45 | 101.32 | 209.3 | 184.29 | 278.72 | 114.85 | 37.74 | 141.23 | 2.9K | 588.23 | 377.13 | 332.54 | 153.26 | 66.6 | 47.31 | 26.84 | 45 | - |
| Inventory | 0 | 0 | 38.71M | 0 | 0 | 0 | 0 | 0 | -1.17M | -436K | -475K | -1.21M | -963K | 0 | -752K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 530K | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 610.14 | - | 11.25K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 184.25M | 121.25M | 6.91M | 5.99M | 4.36M | 364K | 363K | 270K | 269K | 268K | 268K | 267K | 266K | 795K | 794K | 793K | 792K | 791K | 816K | 2.44M | 0 | 0 | 530K | 530K | 530K | 703K | 364K | 31.9M | 8.9M | 18.5M | 12.6M |
| Total Non-Current Assets | 35.59M | 50.27M | 102.79M | 52.73M | 10.33M | 38.83M | 70.87M | 23.91M | 19.23M | 14.34M | 14.14M | 32.87M | 19.11M | 287K | 1.38M | 34.42M | 38.57M | 62.6M | 7.97M | 5.52M | 3.65M | 5.6M | 7.1M | 6.31M | 9.9M | 24.54M | 79.44M | 23.3M | 18.7M | 2.6M | 3.8M |
| Property, Plant & Equipment | 1M | 884K | 4.19M | 4.73M | 4.94M | 5.38M | 5.95M | 2.9M | 59K | 102K | 183K | 207K | 173K | 92K | 974K | 1.24M | 3.09M | 3.94M | 4.39M | 4.08M | 2.48M | 2.75M | 2.09M | 1.68M | 2.44M | 3.59M | 3.68M | 3.8M | 2.3M | 2.4M | 3M |
| Fixed Asset Turnover | 88.06x | 208.01x | 18.37x | 0.05x | 0.12x | 0.26x | 0.04x | 0.16x | 18.07x | 10.44x | 33.67x | 175.71x | 6.66x | 13.95x | 2.78x | 1.96x | 1.15x | 0.44x | 0.64x | 1.87x | 1.32x | 0.11x | 0.50x | 0.70x | 0.51x | 1.01x | 1.80x | 1.42x | 2.96x | 3.04x | 1.77x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 188K | 377K | 1.13M | 3.82M | 6.68M | 9.55M | 12.41M | 15.3M | 0 | 0 | 0 |
| Long-Term Investments | 149.78M | 41.29M | 94.52M | 43.3M | 0 | 28.65M | 63.39M | 19.65M | 18.58M | 14.24M | 13.95M | 32.66M | 18.93M | 0 | 0 | 32.13M | 34.41M | 56M | 1M | 55K | 220K | 331K | 489K | 401K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 7.9M | 8.1M | 4.08M | 4.7M | 5.39M | 4.8M | 1.53M | 1.35M | 585K | 0 | 0 | 0 | 0 | 195K | 410K | 1.05M | 1.06M | 2.67M | 2.59M | 1.39M | 1.17M | 2.47M | 3.88M | 804K | 772K | 11.4M | 63.34M | 4.2M | 16.4M | 200K | 800K |
| Total Assets | 534.12M | 570.54M | 593.78M | 394.08M | 190.57M | 226.03M | 270.73M | 165.52M | 185.28M | 110.31M | 130.25M | 148.76M | 172.51M | 67.34M | 99.8M | 160.05M | 233.58M | 180.38M | 176.22M | 218.9M | 220.8M | 201.24M | 131.87M | 118.11M | 60.67M | 96.23M | 114.03M | 63.7M | 44.5M | 26.1M | 28.8M |
| Asset Turnover | 0.35x | 0.32x | 0.13x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x | 0.01x | 0.01x | 0.05x | 0.24x | 0.01x | 0.02x | 0.03x | 0.02x | 0.02x | 0.01x | 0.02x | 0.03x | 0.01x | 0.00x | 0.01x | 0.01x | 0.02x | 0.04x | 0.06x | 0.08x | 0.15x | 0.28x | 0.18x |
| Asset Growth % | 42.11% | -3.91% | 50.68% | 106.78% | -15.69% | -16.51% | 63.57% | -10.67% | 67.96% | -15.31% | -12.44% | -13.77% | 156.16% | -32.52% | -37.64% | -31.48% | 29.49% | 2.36% | -19.5% | -0.86% | 9.72% | 52.6% | 11.65% | 94.69% | -36.95% | -15.61% | 79.01% | 43.15% | 70.5% | -9.38% | - |
| Total Current Liabilities | 73.57M | 111.54M | 88.3M | 108.07M | 76.69M | 45.52M | 30.94M | 28.16M | 7.55M | 6.52M | 7.87M | 6.63M | 41.8M | 7.59M | 14.15M | 13.44M | 40.85M | 7.46M | 7.71M | 12.72M | 46.78M | 9.33M | 8.46M | 9.82M | 9.38M | 10.31M | 8.13M | 7.9M | 3.6M | 3.7M | 3.6M |
| Accounts Payable | 0 | 11.26M | 8.6M | 6.16M | 10.19M | 6.69M | 6.92M | 1.18M | 982K | 503K | 225K | 160K | 1.03M | 1.4M | 3.43M | 2.98M | 3.46M | 2.18M | 2.41M | 2.86M | 1.96M | 1.91M | 2.54M | 1.3M | 1.59M | 1.34M | 1.46M | 1.3M | 1.2M | 700K | 800K |
| Days Payables Outstanding | 113.44 | 865.92 | 2.5K | - | - | - | 50.46 | 8.41 | 28.17 | 21.76 | 5.59 | 6.1 | 42.36 | 55.82 | 49.71 | - | - | - | - | - | - | - | - | - | - | - | -114.45 | -128.24 | -257.65 | -159.69 | -243.33 |
| Short-Term Debt | 0 | 18.45M | 0 | 46.89M | 20.95M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 55K | 2.6M | 5.04M | 5.51M | 825K | 923K | 1.2M | 900K | 1M | 1.2M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35M | 0 | 0 | 0 | 350K | 700K | 27K | 241K | 1.16M | 2.18M | 477K | 227K | 543K | 767K | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 73.57M | 80.84M | 43.18M | 13.76M | 11.53M | 8.1M | 8.22M | 4.83M | 3.6M | 2.36M | 0 | 0 | 1.55M | 2.24M | 5.5M | 7.43M | 28.21M | 897K | 1.18M | 2.9M | 38.5M | 4.89M | 0 | 0 | 0 | 4.39M | 5.74M | 5.4M | 1.5M | 2M | 1.6M |
| Current Ratio | 6.78x | 4.66x | 5.56x | 3.16x | 2.35x | 4.11x | 6.46x | 5.03x | 21.99x | 14.73x | 14.76x | 17.47x | 3.67x | 8.84x | 6.96x | 9.34x | 4.77x | 15.80x | 21.82x | 16.78x | 4.64x | 20.97x | 14.75x | 11.38x | 5.41x | 6.95x | 4.26x | 5.11x | 7.17x | 6.35x | 6.94x |
| Quick Ratio | 6.78x | 4.66x | 5.12x | 3.16x | 2.35x | 4.11x | 6.46x | 5.03x | 22.15x | 14.80x | 14.82x | 17.65x | 3.69x | 8.84x | 7.01x | 9.34x | 4.77x | 15.80x | 21.82x | 16.78x | 4.64x | 20.97x | 14.75x | 11.38x | 5.41x | 6.90x | 4.26x | 5.11x | 7.17x | 6.35x | 6.94x |
| Cash Conversion Cycle | 549.72 | - | 8.94K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 231.44M | 233.13M | 225.16M | 38.06M | 33.88M | 54.1M | 28.84M | 2.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 350K | 52K | 505K | 105K | 1.21M | 1.35M | 1.97M | 21.55M | 24.38M | 41.99M | 29.6M | 8.1M | 1.3M | 1.6M |
| Long-Term Debt | 0 | 231.68M | 118.48M | 35.05M | 30.21M | 49.83M | 24.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 645K | 1.15M | 20.52M | 16.59M | 32.44M | 17.1M | 8.1M | 1.3M | 1.6M |
| Capital Lease Obligations | 4.97M | 1.45M | 2.27M | 3.01M | 3.67M | 4.27M | 4.8M | 2.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -707K | -815K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 231.44M | 0 | 104.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 427K | 0 | 0 | 0 | 815K | 1.03M | 7.78M | 9.55M | 12.5M | 0 | 0 | 0 |
| Total Liabilities | 305.01M | 344.67M | 313.46M | 146.13M | 110.58M | 99.62M | 59.78M | 30.36M | 7.55M | 6.52M | 7.87M | 6.63M | 41.8M | 7.59M | 14.15M | 13.44M | 40.85M | 7.8M | 7.76M | 13.22M | 46.88M | 10.54M | 9.81M | 11.79M | 30.93M | 34.69M | 50.11M | 37.5M | 11.7M | 5M | 5.2M |
| Total Debt | 0 | 251.57M | 121.72M | 85.9M | 55.75M | 55M | 29.72M | 2.55M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 55K | 3.25M | 6.19M | 26.02M | 17.42M | 33.36M | 18.3M | 9M | 2.3M | 2.8M |
| Net Debt | -70.78M | 172.13M | 42.7M | 15.88M | -1.09M | 20.13M | 19.79M | -11.09M | -10.84M | -16.6M | -13.08M | -21.52M | -43.06M | -12.99M | -22.86M | -16.11M | -45.97M | -34.6M | -109.35M | -146.03M | -135.88M | -96.58M | -6.6M | -6.63M | 21.42M | -1.35M | 3.37M | 10.5M | -7.4M | -1.8M | -9.6M |
| Debt / Equity | 0.00x | 1.11x | 0.43x | 0.35x | 0.70x | 0.44x | 0.14x | 0.02x | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00x | 0.03x | 0.06x | 0.87x | 0.28x | 0.52x | 0.70x | 0.27x | 0.11x | 0.12x |
| Debt / EBITDA | -0.00x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 1.95x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -2.40x | -1.63x | -8.43x | -21.15x | -19.62x | -30.05x | -101.20x | - | - | - | -369.23x | 1.52x | -435.00x | -685.34x | -294.63x | -407.66x | -1135.50x | -491.15x | -720.90x | -616.07x | -364.31x | -81.27x | -53.77x | -41.01x | -47.16x | -34.88x | -2.13x | - | -14.00x | - | -30.50x |
| Total Equity | 229.11M | 225.87M | 280.32M | 247.95M | 80M | 126.42M | 210.95M | 135.16M | 177.73M | 103.8M | 122.38M | 142.13M | 130.71M | 59.76M | 85.65M | 146.6M | 192.74M | 172.58M | 168.46M | 205.67M | 173.92M | 190.71M | 122.06M | 106.32M | 29.74M | 61.54M | 63.92M | 26.2M | 32.8M | 21.1M | 23.6M |
| Equity Growth % | -64.3% | -19.42% | 13.06% | 209.94% | -36.72% | -40.07% | 56.08% | -23.96% | 71.23% | -15.18% | -13.89% | 8.73% | 118.74% | -30.23% | -41.57% | -23.94% | 11.68% | 2.45% | -18.1% | 18.26% | -8.8% | 56.23% | 14.8% | 257.5% | -51.67% | -3.72% | 143.96% | -20.12% | 55.45% | -10.59% | - |
| Book Value per Share | 0.34 | 0.34 | 0.43 | 0.43 | 0.21 | 0.39 | 0.78 | 0.71 | 1.01 | 0.65 | 0.77 | 0.87 | 0.85 | 0.47 | 0.67 | 1.18 | 1.97 | 1.96 | 2.15 | 2.77 | 2.63 | 3.29 | 2.72 | 3.43 | 1.21 | 2.78 | 3.06 | 1.69 | 2.87 | 2.00 | 3.05 |
| Total Shareholders' Equity | 229.11M | 225.87M | 280.32M | 247.95M | 80M | 126.42M | 210.95M | 135.16M | 177.73M | 103.8M | 122.38M | 142.13M | 130.71M | 59.76M | 85.65M | 146.6M | 192.74M | 172.58M | 168.46M | 205.67M | 173.92M | 190.71M | 122.06M | 106.32M | 29.74M | 61.54M | 63.92M | 26.2M | 32.8M | 21.1M | 23.6M |
| Common Stock | 0 | 640K | 606K | 545K | 390K | 324K | 310K | 200K | 186K | 160K | 159K | 159K | 157K | 131K | 130K | 131K | 123K | 92K | 81K | 76K | 70K | 65K | 52K | 39K | 25K | 24K | 22K | 0 | 0 | 0 | 0 |
| Retained Earnings | 0 | -1.86B | -1.77B | -1.6B | -1.41B | -1.27B | -1.16B | -1.08B | -1.01B | -985.84M | -957.92M | -928.39M | -928.43M | -892.76M | -854.38M | -785.5M | -688.65M | -577.27M | -506.89M | -444.87M | -399.09M | -369.6M | -336.07M | -255.67M | -225.78M | -191.88M | -149.8M | -104M | -57.5M | -46.1M | -36.5M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 269K | 261K | 185K | -219K | -173K | 78K | 132K | -183K | -207K | -53K | -213K | -84K | -14K | 40K | -91K | -96K | -406K | 40K | 33K | -213K | -860K | -883K | -744K | -598K | -202K | -314K | -1M | -4.8M | -3.7M | -2.5M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital intensive commercial ramp
As reported in recent financial statements, Geron's total assets have fluctuated significantly, reaching $534.1 million in 2026Q1, while the persistent accumulation of a $1.9 billion deficit in retained earnings underscores the long-term capital intensity required to bring their lead asset, imetelstat, to the commercial market.
The trajectory of the balance sheet reflects a company in the early stages of a high-stakes commercial transition where asset growth is increasingly offset by operational cash consumption. Investors should monitor whether the recent revenue expansion can eventually stabilize the asset base without requiring further dilutive financing.
Based on the provided quarterly data, Geron's debt profile has shifted from $85.9 million in 2023Q4 to a peak of $251.6 million in 2025Q4 before being eliminated by 2026Q1, suggesting a volatile approach to capital structure management during the critical Rytelo launch phase.
The rapid deleveraging observed in the most recent quarter may indicate a strategic effort to clean up the balance sheet, yet the underlying reliance on external capital remains a structural concern. This volatility suggests that the company's ability to maintain a debt-free status is highly contingent on the success of its commercial adoption curve.
According to recent SEC filings, Geron's cash and equivalents stood at $70.8 million as of 2026Q1, a figure that appears insufficient given the company's ongoing negative operating margins and the substantial capital requirements needed to support the full-scale commercial launch of their primary therapeutic asset.
While the current ratio of 6.78 suggests a superficial level of liquidity, the actual cash runway appears limited when measured against the high burn rate associated with commercial infrastructure. This liquidity position warrants close investigation, as it may necessitate further capital raises to sustain operations through the next phase of growth.
As indicated by the financial statements, equity has remained under pressure, totaling $229.1 million in 2026Q1, primarily due to the massive $1.9 billion accumulated deficit that reflects decades of R&D investment and the inherent risks of the biotechnology development cycle.
The quality of equity is currently compromised by the lack of retained earnings, which forces the company to rely on external equity markets for survival. Investors should consider that any future capital needs will likely result in further dilution, potentially impacting the long-term value proposition for existing shareholders.
Quick answers to the most common questions about buying GERN stock.
As of 2025, Geron Corporation (GERN) had total assets of $570.5M including $520.3M in current assets.
Geron Corporation (GERN) carries total debt of $251.6M, offset by $359.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Geron Corporation (GERN) has total shareholders' equity (book value) of $225.9M ($0.34 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Geron Corporation (GERN) reported a current ratio of 4.66x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.